Frontlight ResearchEarly access
Taking peopleNo phase
Survey on Epidemiology of Hypoparathyroidism in France
Key facts
- Who runs it
- European Georges Pompidou Hospital
- Where
- France57 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 3,000 people, planned
- Started
- Jul 2016
- Expected to end
- Sept 2031
- Type of study
- Observational
- Record updated
- 24 September 2024
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- patient fro whom chronic hypoparathyroidism is diagnosed
- patient living in France
Who cannot take part
- patient who does not want his data to be collected in this registry
- pseudo-hypoparathyroidism
- acute hypoparathyroidism
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.
The group in the trial
- Hypoparathyroidism
No intervention.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Epi-Hypo: Survey on Epidemiology of Hypoparathyroidism in France
- Record updated
- 24 September 2024